The Baseline Antimullerian Hormone (AMH) Level As an Independent Predictor of Live Birth Rate of Frozen-Thawed Embryo Transfers: a Multivariate Analysis of 828 Cycles
X. Li,R. Huang,C. Fang,J. Li,X. Liang
DOI: https://doi.org/10.1016/j.fertnstert.2016.07.512
IF: 6.7
2016-01-01
Fertility and Sterility
Abstract:The aim of this study was to assess the prognostic effect of AMH in frozen-thawed embryo transfers. A retrospective cohort study. All non-polycystic ovary patients who underwent their first frozen-thawed embryo transfers in our unit and had basal serum AMH evaluated between 2010 and 2015 were evaluated in this retrospective study. AMH was measured using the enzyme amplified two-site immunoassay (ELISA) provided by Beckman Coulter (AMH Gen II ELISA, Beckman Coulter). Individualized controlled ovarian hyper-stimulation (COH) protocols included long GnRH agonist, GnRH antagonist and minimal stimulation protocols, based on individual patient characteristics. When at least two follicles reached 18 mm in diameter, 5000-10,000 IU hCG (Ovidrel, Merck Serono) was adopted to achieve final follicular maturation and oocyte retrieval performed 32-36 hours later. Intracytoplasmic sperm injection was performed if the concentration of motile sperm was <1×106/mL, otherwise a conventional in vitro fertilization was used. Vitrification was performed for embryo freezing with the use of a Cryotop (Kitazato Corp.) device. Embryo transfer was operated under trans-vaginal sonography guidance. The primary outcome is Live birth rate, which was defined as rate of deliveries that resulted in at least one live born baby per transfer cycle. Chi-square and binary regression were used for data analysis. A P<0.05 indicated significant result. In total, 828 patients were included. We grouped them into three groups based on their baseline AMH concentration: low AMH group (<25th), middle AMH (25th- 75th) and high AMH level (>75th). The results showed lower AMH level was associated with significantly lower implantation rate (21.9% vs. 43.2% vs. 58.8%, P<0.001), clinical pregnancy rate (32.0% vs. 55.2% vs. 65.7%, P<0.001), live birth rate (21.8% vs. 43.6% vs. 52.7%, P<0.001) but higher miscarriage rate (31.8% vs. 17.5% vs. 15.4% P=0.014). After stratifying the patients into two age groups, being younger or older than 35 years, we still observed significant influence of AMH on outcomes in all patients in both age groups. Furthermore, serum AMH kept significant in multivariate analysis when adjusting covariates (i.e. age, FSH, AFC, endometrium thickness, endometrium preparation protocols, number of embryos transferred, etiology of infertility). The area under the curve (AUC) for serum AMH, age, AFC and FSH were 0.635, 0.634, 0.615 and 0.543 respectively, for predicting live birth. Our results demonstrated that baseline AMH was an independent predictive factor of live birth rate of frozen embryo transfers, irrespective of maternal age. It had only moderate predictive value on predicting live birth, superior to that of AFC and FSH.